Lack of squamous cell lung carcinoma in vitro chemosensitivity to various drug regimens in the adenosine triphosphate cell viability chemosensitivity assay

Acta Biochimica Polonica

Volumn 46, Issue 2, 1999, Pages 299-302

  Vogt, Ulf ^a   Striehn, Eberhard ^b   Bosse, Ulrich ^c   Klinke, Folkert ^b   Falkiewicz, Bogdan ^d  

^a European Laboratory Association   (Germany)

^b St Elisabeth Hospital   (Germany)

^c Institute of Pathology   (Germany)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

Antineoplastic agents; Antitumor drug screening assays; Cultured tumor cells; Drug resistance; Squamous cell lung carcinoma; Topotecan

Indexed keywords

ANTINEOPLASTIC AGENT; TOPOTECAN;

AGED; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG RESISTANCE; HUMAN; LUNG TUMOR; MIDDLE AGED; PATHOLOGY; PILOT STUDY; SQUAMOUS CELL CARCINOMA;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PILOT PROJECTS; TOPOTECAN; TUMOR CELLS, CULTURED;

EID: 0032607843     PISSN: 0001527X     EISSN: None     Source Type: Journal    
DOI: 10.18388/abp.1999_4163     Document Type: Article

References (15)

1. Andreotti, P.E., Linder, D., Hartmann, D.M., Cree, I.A., Pazzagli, M. & Bruckner, H.W. (1994) J. Biolumin. Chemilumin. 9, 373-378.
2. Andreotti, P.E., Cree, I.A., Kurbacher, C.M., Hartmann, D.M., Linder, D., Harel, G., Gleiberman, I., Caruso, P.A., Ricks, S.H., Untch, M., Sartori, C. & Bruckner, H.W. (1995) Cancer Res. 55, 5276-5282.
3. Cree, I.A., Kurbacher, C.M., Untch, M., Sutherland, L.A., Hunter, E.M., Subedi, A.M.C., James, E.A., Dewar, J.A., Preece, P.E., Andreotti, P.E. & Bruckner, H.W. (1996) Anti-Cancer Drugs 7, 630-635.
4. Cree, I.A. & Kurbacher, C.M. (1997) Anti-Cancer Drugs 8, 541-548.
5. De Vita, V.T., Jr. (1997) in Cancer: Principles and Practice of Oncology (De Vita, V.T., Jr., Hellman, S. & Rosenberg, S.A., eds.) pp. 333-347, Lippincott-Raven Publishers, Philadelphia.
6. Hunter, E.M., Sutherland, L.A., Cree, I.A., Subedi, A.M.C., Hartmann, D.M., Linder, D. & Andreotti, P.E. (1994) Anti-Cancer Drugs 5, 171-176.
7. Köchli, O.R., Sevin, B.-U., Averette, H.E. & Haller, U. (1994a) Contrib. Gynecol. Obstet. 19, 12-23.
8. Köchli, O.R., Perras, J.P. & Sevin, B.-U. (1994b) Contrib. Gynecol. Obstet. 19, 108-121.
9. Köchli, O.R., Sevin, B.U., Perras, J.P., Angioli, R., Steren, A., Rodriguez, M., Ganjei, P. & Averette, H.E. (1994c) Oncology 51, 35-41.
10. Kurbacher, C.M., Cree, I.A., Bruckner, H.W., Brenne, U., Kurbacher, J.A., Mueller, K., Ackermann, T., Gilster, T.J., Wilhelm, L.M., Engel, H., Mallmann, P.K. & Andreotti, P.E. (1998) Anti-Cancer Drugs 9, 51-57.
11. Lilenbaum, R.C., Langenberg, P. & Dickersin, K. (1998) Cancer 82, 116-126.
12. Mountain, C.F. (1997) Chest 111, 1710-1717.
13. Vogt, U., Falkiewicz, B., Striehn, E., Bosse, U. & Klinke, F. (1998) Diagn. Lab. 34 (Suppl. 1), 57 Abstract.
14. Zabel, M., Kaczmarek, A., Łukianow, R., Ramlau, R. & Górny, A. (1992) Nowotwory 42, 187-192 (in Polish).
15. Zabel, M., Kaczmarek, A., Rozmiarek, A. & Markowska, J. (1997) Współczesna Onkologia 2, 17-19 (in Polish).